Eur J Pediatr Surg 2010; 20(5): 302-306
DOI: 10.1055/s-0030-1254149
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Management of Prenatally Diagnosed Abdominal Lymphatic Malformations

C. Oliveira1 , 2 , P. Sacher2 , M. Meuli2
  • 1The Hospital for Sick Children, Department of General Surgery, Toronto, Canada
  • 2Children's University Hospital Zurich, Department of Pediatric Surgery, Zurich, Switzerland
Further Information

Publication History

received February 19, 2010

accepted after revision April 05, 2010

Publication Date:
24 June 2010 (online)

Abstract

Introduction: Abdominal lymphatic malformations (ALM) are rare congenital malformations that can regress spontaneously or lead to serious complications. Thus, the appropriate management may be challenging, particularly since pertinent literature is missing. We present our experience in the management of 5 patients with prenatally diagnosed ALM and their outcome and propose a decision-making algorithm.

Material and methods: We retrospectively reviewed the history, diagnostics, therapy, complications, and outcome of 5 patients with a prenatal diagnosis of ALM, referred to our department between January 2006 and February 2008.

Results: ALM was prenatally diagnosed by ultrasound in all patients (gestational age 21, 23, 23, 32, and 34 weeks). MRI was performed pre- and postnatally in one patient and postnatally in another. Clinical symptoms ranged from none to respiratory distress and abdominal compartment syndrome. One ALM involuted. 2 patients underwent primary OK-432 treatment. This led to a 70% size reduction in one patient. The other developed massive intracystic bleeding and required emergency surgery. 2/3 patients with surgery needed segmental bowel resection and 3/3 stayed recurrence-free. Complications included one partial inferior vena cava thrombosis after surgery, one subileus, and one hemorrhage after OK-432 application.

Conclusion: Asymptomatic and regressing ALM are best managed conservatively (“watchful waiting”) while symptomatic ALMs require surgery. Further studies are necessary to determine the ideal timepoint for intervention for non-regressing ALM.

References

  • 1 Mabrut JY, Grandjean JP, Henry L. et al . [IMesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management].  Ann Chir. 2002;  127 343-349
  • 2 Jakob J, Moesta KT, Rau B. [Increasing abdominal pain caused by abdominal tumor in a 21-year-old female].  Chirurg. 2005;  76 175-178
  • 3 Prabhakaran K, Patankar JZ, Loh DL. et al . Cystic lymphangioma of the mesentery causing intestinal obstruction.  Singapore Med J. 2007;  48 e265-e267
  • 4 de Perrot M, Rostan O, Morel P. et al . Abdominal lymphangioma in adults and children.  Br J Surg. 1998;  85 395-397
  • 5 Goh BK, Tan YM, Ong HS. et al . Intra-abdominal and retroperitoneal lymphangiomas in pediatric and adult patients.  World J Surg. 2005;  29 837-840
  • 6 Steyaert H, Guitard J, Moscovici J. et al . Abdominal cystic lymphangioma in children: benign lesions that can have a proliferative course.  J Pediatr Surg. 1996;  31 677-680
  • 7 de Lagausie P, Bonnard A, Berrebi D. et al . Abdominal lymphangiomas in children: interest of the laparoscopic approach.  Surg Endosc. 2007;  21 1153-1157
  • 8 Chateil JF, Brun M, Vergnes P. et al . Abdominal cystic lymphangiomas in children: presurgical evaluation with imaging.  Eur J Pediatr Surg. 2002;  12 13-18
  • 9 Rha SE, Byun JY, Kim HH. et al . Prenatal sonographic and MR imaging findings of extensive fetal lymphangioma: a case report.  Korean J Radiol. 2003;  4 260-263
  • 10 Alqahtani A, Nguyen LT, Flageole H. et al . 25 years' experience with lymphangiomas in children.  J Pediatr Surg. 1999;  34 1164-1168
  • 11 Okazaki T, Iwatani S, Yanai T. et al . Treatment of lymphangioma in children: our experience of 128 cases.  J Pediatr Surg. 2007;  42 386-389
  • 12 Martinot V, Descamps S, Fevrier P. et al . [Evaluation of the treatment of cystic lymphangioma by percutaneous injection of Ethibloc in 20 patients].  Arch Pediatr. 1997;  4 8-14
  • 13 Molitch HI, Unger EC, Witte CL. et al . Percutaneous sclerotherapy of lymphangiomas.  Radiology. 1995;  194 343-347
  • 14 Guvenc BH, Ekingen G, Tuzlaci A. et al . Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy.  Pediatr Surg Int. 2005;  21 595-598
  • 15 Ogita S, Tsuto T, Nakamura K. et al . OK-432 therapy for lymphangioma in children: why and how does it work?.  J Pediatr Surg. 1996;  31 477-480
  • 16 Hancock BJ, St-Vil D, Luks FI. et al . Complications of lymphangiomas in children.  J Pediatr Surg. 1992;  27 220-224 ; discussion 224–226
  • 17 Crombleholme TM, D'Alton M, Cendron M. et al . Prenatal diagnosis and the pediatric surgeon: the impact of prenatal consultation on perinatal management.  J Pediatr Surg. 1996;  31 156-162 ; discussion 162–153
  • 18 Murat I, Constant I, Maud'huy H. Perioperative anaesthetic morbidity in children: a database of 24 165 anaesthetics over a 30-month period.  Paediatr Anaesth. 2004;  14 158-166
  • 19 Loepke AW, Soriano SG. An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function.  Anesth Analg. 2008;  106 1681-1707
  • 20 Lorken M, Marnitz U, Manegold E. et al . [Intra-abdominal lymphangioma].  Chirurg. 2001;  72 72-77
  • 21 Malpas TJ, MacLachlan N, Dykes E. et al . Prenatal intestinal perforation and intra-abdominal lymphangioma.  Prenat Diagn. 2007;  27 882-883
  • 22 Kosir MA, Sonnino RE, Gauderer MW. Pediatric abdominal lymphangiomas: a plea for early recognition.  J Pediatr Surg. 1991;  26 1309-1313

Correspondence

Dr. Carol Oliveira

The Hospital for Sick Children

Department of General Surgery

555 University Ave

M5G 1X8 Toronto

Canada

Phone: +1 416 813 6996

Fax: +1 416 813 7477

Email: carol.oliveira@sickkids.ca

    >